Literature DB >> 20402204

Viral hepatitis and injection drug use in Appalachian Kentucky: a survey of rural health department clients.

W Jay Christian1, Claudia Hopenhayn, Amy Christian, Deana McIntosh, Alvaro Koch.   

Abstract

OBJECTIVES: We identified correlates of exposure to hepatitis B and C viruses among health department clients in Appalachian Kentucky, a rural region noted for high poverty and low education. Additionally, we investigated risk factors for transmission, and the frequency of use of preventive measures.
METHODS: Patients screened for hepatitis B or C at four county health departments in Appalachian Kentucky were administered a routine prescreening questionnaire and an additional survey designed to obtain detailed personal and behavioral risk factor data. These data were linked to produce a more comprehensive dataset for analysis, including test results, which were attached to the prescreening questionnaire.
RESULTS: In total, 92 health department clients participated in the study survey. Of these, test results were available for 80 of the clients. Very few subjects who enrolled in this study tested positive for hepatitis B. Twelve out of 80 participants (15%) tested positive for previous exposure to hepatitis C. No participants reported having human immunodeficiency virus.
CONCLUSIONS: Transmission of hepatitis C in these rural Appalachian communities is predominantly due to injection drug use. Patients with hepatitis C exposure are similar in their demographic and risk profiles as those seen in urban areas and, despite small numbers, can have a serious impact on small, rural public health systems.

Entities:  

Mesh:

Year:  2010        PMID: 20402204      PMCID: PMC2789824          DOI: 10.1177/003335491012500116

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  18 in total

1.  The Massachusetts HIV, hepatitis, addiction services integration (HHASI) experience: responding to the comprehensive needs of individuals with co-occurring risks and conditions.

Authors:  Heidi L Hoffman; Carolyn A Castro-Donlan; Victoria M Johnson; Daniel R Church
Journal:  Public Health Rep       Date:  2004 Jan-Feb       Impact factor: 2.792

2.  Integrating viral hepatitis prevention into public health programs serving people at high risk for infection: good public health.

Authors:  Joanna Buffington; T Stephen Jones
Journal:  Public Health Rep       Date:  2007       Impact factor: 2.792

Review 3.  Hepatitis C in Prince Edward Island: a descriptive review of reported cases, 1990-1995.

Authors:  E Stratton; L Sweet; A Latorraca-Walsh; P R Gully
Journal:  Can J Public Health       Date:  1997 Mar-Apr

Review 4.  Sexual activity as a risk factor for hepatitis C.

Authors:  Norah A Terrault
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

5.  Lack of evidence for the heterosexual transmission of hepatitis C.

Authors:  G Neumayr; A Propst; H Schwaighofer; G Judmaier; W Vogel
Journal:  QJM       Date:  1999-09

6.  An epidemic of hepatitis B among injection drug users in a rural area.

Authors:  C Poulin; T Gyorkos; L Joseph; W Schlech; S Lee
Journal:  Can J Public Health       Date:  1992 Mar-Apr

7.  Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City.

Authors:  Don C Des Jarlais; Theresa Diaz; Theresa Perlis; David Vlahov; Carey Maslow; Mary Latka; Russell Rockwell; Vincent Edwards; Samuel R Friedman; Edgar Monterroso; Ian Williams; Richard S Garfein
Journal:  Am J Epidemiol       Date:  2003-03-01       Impact factor: 4.897

8.  Hepatitis C incidence--a comparison between injection and noninjection drug users in New York City.

Authors:  Crystal M Fuller; Danielle C Ompad; Sandro Galea; Yingfeng Wu; Beryl Koblin; David Vlahov
Journal:  J Urban Health       Date:  2004-03       Impact factor: 3.671

9.  High seroprevalence of bloodborne viruses among street-recruited injection drug users from Buenos Aires, Argentina.

Authors:  Mercedes Weissenbacher; Diana Rossi; Graciela Radulich; Sergio Sosa-Estáni; Marcelo Vila; Enrique Vivas; María M Avila; Paloma Cuchi; Jorge Rey; Liliana Martínez Peralta
Journal:  Clin Infect Dis       Date:  2003-12-15       Impact factor: 9.079

10.  The future face of coinfection: prevalence and incidence of HIV and hepatitis C virus coinfection among young injection drug users.

Authors:  Cari L Miller; Evan Wood; Patricia M Spittal; Kathy Li; James C Frankish; Paula Braitstein; Julio S G Montaner; Martin T Schechter
Journal:  J Acquir Immune Defic Syndr       Date:  2004-06-01       Impact factor: 3.731

View more
  11 in total

1.  Epidemiology of hepatitis C virus in Pennsylvania state prisons, 2004-2012: limitations of 1945-1965 birth cohort screening in correctional settings.

Authors:  Sarah Larney; Madeline K Mahowald; Nicholas Scharff; Timothy P Flanigan; Curt G Beckwith; Nickolas D Zaller
Journal:  Am J Public Health       Date:  2014-04-17       Impact factor: 9.308

2.  Rural risk environments for hepatitis c among young adults in appalachian kentucky.

Authors:  David H Cloud; Umedjon Ibragimov; Nadya Prood; April M Young; Hannah L F Cooper
Journal:  Int J Drug Policy       Date:  2019-05-18

3.  Association of opioid agonist therapy with lower incidence of hepatitis C virus infection in young adult injection drug users.

Authors:  Judith I Tsui; Jennifer L Evans; Paula J Lum; Judith A Hahn; Kimberly Page
Journal:  JAMA Intern Med       Date:  2014-12       Impact factor: 21.873

4.  Injection drug use and hepatitis C virus infection in young adult injectors: using evidence to inform comprehensive prevention.

Authors:  Kimberly Page; Meghan D Morris; Judith A Hahn; Lisa Maher; Maria Prins
Journal:  Clin Infect Dis       Date:  2013-08       Impact factor: 9.079

5.  The opioid and related drug epidemics in rural Appalachia: A systematic review of populations affected, risk factors, and infectious diseases.

Authors:  Christine A Schalkoff; Kathryn E Lancaster; Bradley N Gaynes; Vivian Wang; Brian W Pence; William C Miller; Vivian F Go
Journal:  Subst Abus       Date:  2019-08-12       Impact factor: 3.716

Review 6.  Injection drug use, HIV/HCV, and related services in nonurban areas of the United States: A systematic review.

Authors:  Catherine E Paquette; Robin A Pollini
Journal:  Drug Alcohol Depend       Date:  2018-05-08       Impact factor: 4.492

7.  Hepatitis C vaccine clinical trials among people who use drugs: potential for participation and involvement in recruitment.

Authors:  April M Young; Dustin B Stephens; Hanan A Khaleel; Jennifer R Havens
Journal:  Contemp Clin Trials       Date:  2014-12-30       Impact factor: 2.226

8.  Hepatitis A Outbreaks Associated With the Opioid Epidemic in Kentucky Counties, 2017-2018.

Authors:  Natalie DuPre; Lyndsey Blair; Sarah Moyer; E Francis Cook; Bert Little; Jeffrey Howard
Journal:  Am J Public Health       Date:  2020-07-16       Impact factor: 11.561

9.  Hepatitis C Testing Increased Among Baby Boomers Following The 2012 Change To CDC Testing Recommendations.

Authors:  Joshua A Barocas; Jianing Wang; Laura F White; Abriana Tasillo; Joshua A Salomon; Kenneth A Freedberg; Benjamin P Linas
Journal:  Health Aff (Millwood)       Date:  2017-12       Impact factor: 9.048

10.  Higher risk of incident hepatitis C virus among young women who inject drugs compared with young men in association with sexual relationships: a prospective analysis from the UFO Study cohort.

Authors:  Daniel Tracy; Judith A Hahn; Crystal Fuller Lewis; Jennifer Evans; Alya Briceño; Meghan D Morris; Paula J Lum; Kimberly Page
Journal:  BMJ Open       Date:  2014-05-29       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.